Stock zlab.

Zai Lab Limited analysts consensus, targets, ratings and recommendations | Nasdaq: ZLAB | Nasdaq

Stock zlab. Things To Know About Stock zlab.

Nov 17, 2023 · As of November 17, 2023, 4:00 PM, CST, Zai Lab Ltd - ADR’s stock price was $27.57. Zai Lab Ltd - ADR is up 4.43% from its previous closing price of $26.40. During the last market session, Zai Lab Ltd - ADR’s stock traded between $25.75 and $27.11. Currently, there are 96.88 million shares of Zai Lab Ltd - ADR stock available for purchase. Mar 13, 2023 · anamejia18/iStock via Getty Images. Zai Lab Ltd. (NASDAQ:ZLAB) (9688.HK) is known among China's innovative drug developers for its unique asset-light business model.Unlike its peers that invest ... The stock price for . Zai Lab (NASDAQ: ZLAB) is $27.1 last updated November 29, 2023 at 9:00 PM UTC.View the latest Zai Lab Ltd. ADR (ZLAB) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Zai Lab has generated ($3.12) earnings per share over the last year ( ($3.12) diluted earnings per share). Earnings for Zai Lab are expected to grow in the coming year, from ($3.48) to ($2.84) per share. Zai Lab has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 ...ZLAB Stock Shows Positive Performance with Strong Growth in Earnings and Revenue. On November 8, 2023, ZLAB stock showed positive performance, with a slight increase in its opening price compared to the previous day’s closing price. The stock opened at $29.86, higher than the previous close of $28.34. Throughout the day, the …Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar

As a result of the transaction, Sheeran Josette now holds 1,336,459 shares, worth roughly $0.36 million. Stifel initiated its Canoo Inc [GOEV] rating to a Buy in a research note published on Tuesday, September 16, 2022; the price target was $4. PT values the company’s stock at a premium of 93.25 to its Tuesday closing price.Web

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.Sep 5, 2023 · Shares of Zai Lab ( ZLAB 0.77%) were up more than 10% as of 11 a.m. on Tuesday. The Chinese biotech stock rose after the company announced positive phase 3 trial data regarding Tivdak as a front ... Zai Lab (NASDAQ: ZLAB) does not pay a dividend. Is Zai Lab's dividend stable?The public float for ZLAB is 97.90M, and at present, short sellers hold a 4.14% of that float. On November 30, 2023, the average trading volume of ZLAB was 405.85K shares. ZLAB’s Market Performance. ZLAB stock saw an increase of 2.40% in the past week, with a monthly gain of 11.71% and a quarterly increase of 10.52%.ZLAB Stock Split History. Stock splits give an idea of how and when the stock have either been diluted due to splits. An interesting article explaining the benefit of stock splits A regular split will increase the float and will lower the price of the stock based on the ratio of the split. e.g. 1:4 => For every 1 stock there will be 4 stocks ...Web

ZLAB stock closed at $33.54 and is down -$4.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ZLAB has a roughly average overall score of 59 meaning the stock holds a better value than 59% of stocks at its current price.

ZLAB stock closed at $33.54 and is down -$4.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ZLAB has a roughly average overall score of 59 meaning the stock holds a better value than 59% of stocks at its current price.

Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Zai Lab Ltd have a median target of 65.00, with a high estimate of 123.00 and a low estimate of 37.00. The median ...Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Stock analysis for Zai Lab Ltd (9688:Hong Kong) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Architectural solutions without limits. Through its brands, Silestone, Dekton, and Sensa, Cosentino provides sustainable design surfaces and a global services network to bring any project to life. Ultra compact façades. High-performance flooring. Professional kitchens.ZLAB stock closed at $33.54 and is down -$4.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ZLAB has a roughly average overall score of 59 meaning the stock holds a better value than 59% of stocks at its current price.

Doors for Builders - Wood Entry and Interior Doors from Doors for ...Web32-in x 80-in Steel Universal Reversible Primed Slab Door Single Front Door Solid Core. Model # JW233200005. Find My Store. for pricing and availability. 53. RELIABILT. 36-in x 80-in Steel Left-Hand Inswing Primed Unfinished Prehung Slab Door Single Front Door with Brickmould Insulating Core. Model # 10087327.The fund owned 118,949 shares of the company’s stock after selling 89,647 shares during the quarter. Bank of New York Mellon Corp reduced its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 43.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.Dec 1, 2023 · A high-level overview of Silicon Laboratories Inc. (SLAB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. há 4 dias ... Over the past 3 months, 6 analysts have published their opinion on Zai Lab (NASDAQ:ZLAB) stock. These analysts are typically employed by ...ZLAB Stock Assessment Per Seeking Alpha data, Zai Lab's earnings projections suggest substantial growth, with an almost break-even EPS (-$0.06) and a significant sales increase (67.28% YoY to $825 ...Zai Lab ( NASDAQ: ZLAB) is a biopharmaceutical company dedicated to developing and commercializing innovative treatments for cancer and infectious diseases. The company's product portfolio ...

Dec 1, 2023 · ZLAB is trading at a 37% discount. Price $28.58 Nov 24, 2023 Fair Value $73.17 Nov 24, 2023 Uncertainty Extreme 1-Star Price $956.93 5-Star Price $89.33

Dec 1, 2023 · View Silicon Laboratories, Inc SLAB investment & stock information. Get the latest Silicon Laboratories, Inc SLAB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Nov 20, 2023 · ZLAB Stock Overview Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. About the company Overview Market Screener Sectors ZLAB U.S.: Nasdaq Zai Lab Ltd. ADR Watch Set a price target alert After Hours Last Updated: Dec 1, 2023 4:00 p.m. EST Delayed quote $ 27.50 0.00 0.00% After... Silicon Laboratories Inc EBIT Forecast for 2023 - 2025 - 2030. Silicon Laboratories Inc's EBIT has increased by 234.54% In the last two years, going from $-88.64M to $119.26M. In the next year, analysts expect EBIT to reach $179.83M – an increase of 50.79%. For the next eight years, the forecast is for EBIT to grow by …2015 Gridiron Kings Performance Art Relic #PA-AB Antonio Brown #3/15 PSA 10. $95. 1957 Topps #35 Frank Robinson Rookie SGC 2.5. $200. 2022 Prizm Purple Ice /225 & Tri Color /75 Garrett Wilson. $129. 2022 Kenny Pickett Orange Ice & Orange Flamethrowers /99. $259. 2023 Topps Series 2 Corbin Carroll Stars of MLB SGC 10.A high-level overview of Zai Lab Limited (ZLAB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

ZLAB stock opened at $27.29 on Thursday. The firm has a market capitalization of $2.70 billion, a PE ratio of -8.75 and a beta of 1.06. Zai Lab has a twelve month low of $22.35 and a twelve month ...

Nov 17, 2023 · As of November 17, 2023, 4:00 PM, CST, Zai Lab Ltd - ADR’s stock price was $27.57. Zai Lab Ltd - ADR is up 4.43% from its previous closing price of $26.40. During the last market session, Zai Lab Ltd - ADR’s stock traded between $25.75 and $27.11. Currently, there are 96.88 million shares of Zai Lab Ltd - ADR stock available for purchase.

ZLAB Valuation Summary. In comparison to the median Healthcare stock, ZLAB's price/earnings ratio is 126.34% lower, now standing at -6.4. ZLAB's price/earnings ratio has moved up 30.1 over the prior 74 months. Below are key valuation metrics over time for ZLAB. Stock.Zai Lab Stock Performance. ZLAB opened at $27.29 on Thursday. Zai Lab has a one year low of $22.35 and a one year high of $49.81. The company has a market cap of $2.70 billion, a P/E ratio of -8. ...Nov 29, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Zai Lab stock is Buy based on the current 4 buy ratings for ZLAB. The average twelve-month price prediction for Zai Lab is $79.57 with a high price target of $128.00 and a low price target of $62.50. Learn more on ZLAB's analyst rating history. Nov 29, 2023 · Corporate Profile. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Zai Lab (ZLAB) reports Q3 2023 financial results and corporate updates, with revenue of $69.23M (+20.4% Y/Y) and beating earnings expectations.WebLinks. Disclosure Terms PrivacyZai Lab Stock Up 3.2 %. NASDAQ ZLAB opened at $28.37 on Friday. Zai Lab Limited has a twelve month low of $22.35 and a twelve month high of $49.81. The firm has a market capitalization of $2.80 billion, a PE ratio of -9.09 and a beta of 1.06. The stock’s 50 day moving average is $25.48 and its 200 day moving average is $27.41.Panoramic View. From specs to perks and much more, learn all the fine points of Panoramic Porcelain. Ranging from natural stone to porcelain to quartz, view our award-winning kitchen countertops and bathroom vanity countertops.WebShares of NovoCure Limited ( NASDAQ: NVCR) reached a 52-week low on Tuesday after the medical device maker and its China-based partner Zai Lab ( ZLAB) posted late-stage data for their cancer ...

Mar 6, 2023 · 2. Zai Lab. Zai Lab ( ZLAB -3.01%) is another biopharma company with huge potential, but it's much further along its journey than Compass Pathways: It already has four oncology therapies on the ... Nov 17, 2023 · Silicon Laboratories stock has received a consensus rating of hold. The average rating score is and is based on 9 buy ratings, 12 hold ratings, and 3 sell ratings. What was the 52-week low for ... View Zai Lab Limited Unsponsored ADR ZLAB investment & stock information. Get the latest Zai Lab Limited Unsponsored ADR ZLAB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Find the latest Zai Lab Limited (9688.HK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... ZLAB) latest 6.3% drop adds to a year losses.Instagram:https://instagram. options this weeknasdaq predictionsneurometrixmasterworks io review Get the Latest News and Ratings for ZLAB and Related Stocks. Enter your email address below to receive the latest news and analysts' ratings for Zai Lab and ... short term lease insurancechevron stock split rumors 4 Wall Street research analysts have issued 12-month price objectives for Zai Lab's shares. Their ZLAB share price targets range from $62.50 to $128.00. On average, they expect the company's stock price to reach $79.97 in the next year. This suggests a possible upside of 189.7% from the stock's current price. rare susan b anthony dollar Zai Lab (NASDAQ:ZLAB) President and Chief Operating Officer Josh Smiley purchased 5,000 shares in the company for a transaction value of $134,650 on Nov. 16, the company disclosed in a filing. Zai ...WebFull Company Report for SLAB. View Silicon Laboratories, Inc SLAB investment & stock information. Get the latest Silicon Laboratories, Inc SLAB detailed stock quotes, stock data, Real-Time ECN ...Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the …